GATA2 and Alzheimer disease: Interestingly, previous analysis of DEGs between the entorhinal cortex of AD patients and healthy controls also showed alteration of the retrograde endocannabinoid signaling pathway and predicted GATA1 and GATA2 as the upstream regulators of the identified DEGs in AD [74].